Rungsted Kyst, Denmark

Christian Krog-Jensen



Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • København, DK (2003)
  • Copenhagen, DK (2004)
  • Rungsted Kyst, DK (2005 - 2008)

Company Filing History:


Years Active: 2003-2008

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christian Krog-Jensen: Innovator in Affective and Neurological Disorders

Introduction

Christian Krog-Jensen is a notable inventor based in Rungsted Kyst, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of affective and neurological disorders. With a total of 5 patents to his name, Krog-Jensen's work is recognized for its potential impact on mental health therapies.

Latest Patents

Among his latest patents, Krog-Jensen has developed compounds such as "Heteroaryl derivatives, their preparation and use." This invention focuses on a heteroaryl derivative that is useful for treating various affective disorders, including general anxiety disorder, panic disorder, obsessive-compulsive disorder, depression, social phobia, and eating disorders. Additionally, he has worked on "Indole derivatives," which also target similar affective and neurological disorders, including psychosis.

Career Highlights

Christian Krog-Jensen is currently employed at H. Lundbeck A/S, a company renowned for its dedication to improving the lives of people with brain diseases. His innovative work in drug development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Krog-Jensen collaborates with esteemed colleagues such as Ejner Knud Moltzen and Thomas Ruhland, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christian Krog-Jensen's contributions to the field of pharmaceuticals, particularly in the treatment of mental health disorders, highlight his role as a significant inventor. His ongoing work continues to pave the way for advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…